Recor
Menu
  • About Hypertension
  • Technology
  • Clinical Trials
    • Find a Study Doctor
  • Clinical Evidence
  • About / Contact
    • Management
    • Board of Directors
    • Contact
  • News & Events
Am I a Candidate?
  • Follow us on:
  • Facebook
  • Twitter
  • Instagram

News & Events

ReCor Medical adds another $12m for trial of Paradise renal denervation device

August 28, 2017 by tracyrodriguez

PALO ALTO, Calif., Aug 16, 2017 / ReCor Medical last week added a $12 million contribution from Otsuka Pharmaceutical to the $10 million it raised from the Japanese conglomerate last year for a clinical trial of its Paradise renal denervation device for treating hypertension, ReCor president & CEO Andrew Weiss told MassDevice.com.

Read the interview with CEO Andrew Weiss and MassDevice.com here.

 

About ReCor Medical, Inc.

ReCor Medical is a private medical device company that designs and manufactures a proprietary ultrasound ablation system for renal denervation (RDN) called the Paradise System®. RDN is a new potential therapeutic approach for the treatment of hypertension, one of the most prevalent medical conditions. The Paradise System is approved for sale in the EU and bears a CE mark, but is not approved for sale in the United States. The System’s intravascular catheters denervate renal nerves by combining the protection of water-based cooling of the renal artery with high intensity ultrasound energy for circumferential renal nerve ablation. ReCor has initiated enrollment in its RADIANCE-HTN study, en IDE-approved, randomized, sham-controlled trial to demonstrate the efficacy of the Paradise System in patients with hypertension.  RADIANCE-HTN is being conducted in approximately 35 centers in the United States, Netherlands, UK, France and Germany.

More information on RADIANCE-HTN can be found at:

https://clinicaltrials.gov/ct2/show/NCT02649426?term=radiance&rank=3

For more information about ReCor Medical, please visit www.recormedical.com or contact Andrew M. Weiss, President & CEO, ReCor Medical at aweiss@recormedical.com / +1-650-542-7700.

 

Filed Under: News

Reader Interactions

Primary Sidebar

sidebar-alt

  • About Hypertension
  • Technology
  • Clinical Trials
    • Find a Study Doctor
  • Clinical Evidence
  • About / Contact
    • Management
    • Board of Directors
    • Contact
  • News & Events

Footer

The PARADISE® system is approved for sale in markets regulated by the CE mark.
Investigational Device in the US, Limited by US Federal Law to Investigational Use Only in the United States
© ReCor Medical, Inc. All rights reserved. PARADISE and the Paradise Swirl logo are trademarks of ReCor Medical, Inc.
The PARADISE System is covered by US Patent No. 6763722, 9700372, 9707034, 9943666, 9981108; Other Patents Pending US and OUS.

Sitemap | Contact | Privacy Policy | Terms & Conditions

  • Follow us on:
  • Facebook
  • Twitter
  • Instagram